Advanced search
1 file | 193.22 KB Add to list

Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975

(2003) JOURNAL OF CLINICAL ONCOLOGY. 21(21). p.3909-3917
Author
Organization

Downloads

  • 3909.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 193.22 KB

Citation

Please use this url to cite or link to this publication:

MLA
SMIT, EF, et al. “Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel plus Gemcitabine in Advanced Non-Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975.” JOURNAL OF CLINICAL ONCOLOGY, vol. 21, no. 21, 2003, pp. 3909–17, doi:1854/2151.
APA
SMIT, E., Van Meerbeeck, J., LIANES, P., DEBRUYNE, C., LEGRAND, C., SCHRAMEL, F., … GIACCONE, G. (2003). Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975. JOURNAL OF CLINICAL ONCOLOGY, 21(21), 3909–3917. https://doi.org/1854/2151
Chicago author-date
SMIT, EF, Jan Van Meerbeeck, P LIANES, C DEBRUYNE, C LEGRAND, F SCHRAMEL, H SMIT, et al. 2003. “Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel plus Gemcitabine in Advanced Non-Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975.” JOURNAL OF CLINICAL ONCOLOGY 21 (21): 3909–17. https://doi.org/1854/2151.
Chicago author-date (all authors)
SMIT, EF, Jan Van Meerbeeck, P LIANES, C DEBRUYNE, C LEGRAND, F SCHRAMEL, H SMIT, R GAAFAR, B BIESMA, C MANEGOLD, N NEYMARK, and G GIACCONE. 2003. “Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel plus Gemcitabine in Advanced Non-Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975.” JOURNAL OF CLINICAL ONCOLOGY 21 (21): 3909–3917. doi:1854/2151.
Vancouver
1.
SMIT E, Van Meerbeeck J, LIANES P, DEBRUYNE C, LEGRAND C, SCHRAMEL F, et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975. JOURNAL OF CLINICAL ONCOLOGY. 2003;21(21):3909–17.
IEEE
[1]
E. SMIT et al., “Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975,” JOURNAL OF CLINICAL ONCOLOGY, vol. 21, no. 21, pp. 3909–3917, 2003.
@article{208659,
  author       = {{SMIT, EF and Van Meerbeeck, Jan and LIANES, P and DEBRUYNE, C and LEGRAND, C and SCHRAMEL, F and SMIT, H and GAAFAR, R and BIESMA, B and MANEGOLD, C and NEYMARK, N and GIACCONE, G}},
  issn         = {{0732-183X}},
  journal      = {{JOURNAL OF CLINICAL ONCOLOGY}},
  language     = {{eng}},
  number       = {{21}},
  pages        = {{3909--3917}},
  title        = {{Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975}},
  url          = {{http://doi.org/1854/2151}},
  volume       = {{21}},
  year         = {{2003}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: